help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hofland, L. J.
Right arrow Articles by Lamberts, S. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hofland, L. J.
Right arrow Articles by Lamberts, S. W.

Journal of Clinical Endocrinology & Metabolism, Vol 68, 613-620, Copyright © 1989 by Endocrine Society

ARTICLES

Heterogeneity of growth hormone (GH) release by individual pituitary adenoma cells from acromegalic patients, as determined by the reverse hemolytic plaque assay: effects of SMS 201-995, GH-releasing hormone and thyrotropin-releasing hormone

LJ Hofland, PM van Koetsveld, CC van Vroonhoven, SZ Stefanko and SW Lamberts
Department of Medicine, Erasmus University, Rotterdam, The Netherlands.

We used the reverse hemolytic plaque assay to study the dynamics of GH secretion by individual pituitary adenoma cells from eight acromegalic patients. There was a considerable variation between the adenomas with respect to the percentages of GH-secreting cells (25-78.5%) and also with respect to the amount of GH released per individual pituitary adenoma cell (mean plaque areas varying from 901-3559 micron 2). The GH plaque area frequency distributions from the adenoma cells were not normally distributed, but revealed a preponderance of small plaques, defined as those with areas smaller than the mean plaque area. The large plaques, that is those with areas larger than the mean plaque area, constituted 24-38% of the total cell population from different tumors and accounted for a large fraction (63-80%) of the total plaque area (the total amount of GH released by the adenoma cells). The somatostatin analog SMS 201-995 caused a shift in the GH plaque area frequency distributions toward smaller plaques, but had no effect on the overall percentages of GH plaque-forming cells in three of the five adenomas in which it was studied. This finding suggests that the adenoma cells from these patients that formed large plaques were preferentially inhibited by SMS 201-995. GHRH (studied in two adenomas) and TRH (studied in one adenoma) had no preferential effect on any subpopulation of adenoma cells. We conclude that GH secretion by individual somatotroph adenoma cells is highly variable both within and between adenomas and that SMS 201-995 has a preferential inhibitory effect on a subpopulation of adenoma cells in some adenomas.


This article has been cited by other articles:


Home page
 Mol. Endocrinol.Home page
A. J. Norris, J. A. Stirland, D. W. McFerran, Z. C. Seymour, D. G. Spiller, A. S. I. Loudon, M. R. H. White, and J. R. E. Davis
Dynamic Patterns of Growth Hormone Gene Transcription in Individual Living Pituitary Cells
Mol. Endocrinol., February 1, 2003; 17(2): 193 - 202.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
N. Takasuka, M. R. H. White, C. D. Wood, W. R. Robertson, and J. R. E. Davis
Dynamic Changes in Prolactin Promoter Activation in Individual Living Lactotrophic Cells
Endocrinology, March 1, 1998; 139(3): 1361 - 1368.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1989 by The Endocrine Society